[The comparative study on selective alpha1-blocker and behavioural therapy in the treatment of discoordinated voiding

Paweł Kroll1, Andrzej Jankowski, Jakub Maćkowiak

  • 1Katedra Chirurgii Dzieciecej, Klinika Chirurgii, Traumatologii i Urologii Dzieciecej Akademii Medycznej im K Marcinkowskiego w Poznaniu. pakroll@poczta.onet.pl

Przeglad Lekarski
|August 11, 2006
PubMed

Insights

Selective alpha1-blockers and behavioral therapy both treat childhood detrusor-sphincter discoordination. Alpha1-blockers showed greater effectiveness in improving voiding patterns and uroflowmetry parameters compared to rehabilitation exercises.

Area of Science:

  • Pediatric Urology
  • Urology
  • Pharmacology

Background:

  • Detrusor-sphincter discoordination (DSD) is a common cause of lower urinary tract dysfunction in children.
  • It often presents with recurrent urinary tract infections (UTIs) and irregular micturition patterns.
  • Accurate diagnosis relies on uroflowmetry and post-void residual urine assessment.

Purpose of the Study:

  • To compare the efficacy of selective alpha1-blockers versus behavioral therapy for treating DSD in pediatric patients.
  • To evaluate the impact of each treatment on voiding patterns and uroflowmetry parameters.

Main Methods:

  • A prospective, randomized study involving 60 children (ages 5-17) diagnosed with DSD.
  • Group 1 received selective alpha1-blocker (doxazosin); Group 2 underwent behavioral therapy with timed voiding and proper toilet posture training.
  • Outcomes were assessed after 6 weeks, evaluating voiding patterns, uroflowmetry, and post-void residual urine.

Main Results:

  • Of 57 children completing the study, 21 in the alpha1-blocker group and 17 in the behavioral therapy group showed improvement.
  • Alpha1-blocker treatment led to better outcomes in voiding patterns and uroflowmetry parameters.
  • Side effects (headache, hypotonia, vertigo, epistaxis) were reported in 6 children on alpha1-blockers, with none in the behavioral therapy group.

Conclusions:

  • Both selective alpha1-blockers and behavioral therapy are effective in managing DSD in children.
  • Selective alpha1-blockers monotherapy demonstrated superior efficacy compared to rehabilitation exercises alone.
  • Alpha1-blockers offer a more effective treatment option for DSD in pediatric patients.
Abstract

Related Concept Videos

Operant Conditioning Intervention01:24

Operant Conditioning Intervention

Operant conditioning serves as a foundational principle in therapeutic interventions aimed at modifying maladaptive behaviors. Central to this approach is the notion that behaviors, both adaptive and maladaptive, are learned through reinforcement. By analyzing the environmental factors that reinforce problematic behaviors, clinicians can design interventions to weaken these reinforcements and replace maladaptive behaviors with healthier alternatives.
In operant conditioning, behaviors that are...
Urodynamic Studies: Uroflowmetry01:19

Urodynamic Studies: Uroflowmetry

Uroflowmetry is a non-invasive urodynamic test designed to measure various aspects of urination, including volume, flow rate, and the time to void. This test is crucial for diagnosing and assessing conditions such as bladder outlet obstruction, bladder dysfunction, incomplete bladder emptying, incontinence, and urinary tract blockages caused by benign prostatic hyperplasia (BPH) and urethral strictures.Pre-Test Instructions:Before a uroflowmetry test, patients are typically advised to drink...
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers01:22

Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers

α-Adrenergic antagonists, known as α-blockers, exert their effects by inhibiting α-adrenoceptors, leading to specific physiological actions. α1-blockers and α2-blockers have distinct pharmacological actions and therapeutic applications.
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally, α1-blockers effectively address urinary obstruction...
The Micturition Reflex01:26

The Micturition Reflex

Urination, or micturition involves the coordination of the bladder's detrusor muscle and two sphincters to ensure controlled bladder emptying.
The process begins with bladder filling, where the bladder wall stretches as urine accumulates. This stretching activates the urine storage reflex, mediated by the sacral spinal segments and the pontine storage center. Efferent sympathetic impulses stimulate the detrusor muscle to relax and the internal urethral sphincter to contract, facilitating urine...
Imaging Studies VI: Voiding Cystourethrography and Cystography01:22

Imaging Studies VI: Voiding Cystourethrography and Cystography

Voiding Cystourethrography (VCUG) and Cystography are specialized radiographic procedures used to examine the structure and function of the bladder and urethra.Voiding Cystourethrography (VCUG)A Voiding Cystourethrogram (VCUG) is a diagnostic imaging procedure that assesses the anatomy and function of the lower urinary tract. It focuses on the bladder, bladder neck, and urethra, helping detect abnormalities such as vesicoureteral reflux (VUR)—the backward or reverse flow of urine into the...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...